Long-Term Symptoms Among Adults Tested for SARS-CoV-2 — United States, January 2020–April 2021

What is already known about this topic? Long-term symptoms associated with COVID-19 represent an emerging public health concern. What is added by this report? In a nonprobability-based sample of U.S. adults tested for SARS-CoV-2, symptoms often associated with SARS-CoV-2 infection were common; 65.9%...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MMWR. Morbidity and mortality weekly report 2021-09, Vol.70 (36), p.1235-1241
Hauptverfasser: Wanga, Valentine, Chevinsky, Jennifer R, Dimitrov, Lina V, Gerdes, Megan E, Whitfield, Geoffrey P, Bonacci, Robert A, Nji, Miriam A.M, Hernandez-Romieu, Alfonso C, Rogers-Brown, Jessica S, McLeod, Tim, Rushmore, Julie, Lutfy, Caitlyn, Bushman, Dena, Koumans, Emilia, Saydah, Sharon, Goodman, Alyson B, King, Sallyann M. Coleman, Jackson, Brendan R, Cope, Jennifer R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:What is already known about this topic? Long-term symptoms associated with COVID-19 represent an emerging public health concern. What is added by this report? In a nonprobability-based sample of U.S. adults tested for SARS-CoV-2, symptoms often associated with SARS-CoV-2 infection were common; 65.9% of respondents whose SARS-CoV-2 test results were positive reported symptoms lasting >4 weeks compared with 42.9% of those whose test results were negative. More persons who received positive test results (76.2%) reported persistence (>4 weeks) of at least one initially occurring symptom compared with those whose test results were negative (69.6%). What are the implications for public health practice? These findings can aid efforts to address post-COVID conditions and messaging on potential benefits of vaccination.
ISSN:0149-2195
1545-861X
DOI:10.15585/mmwr.mm7036a1